Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Colon Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy (849-010)

  • Details

ClinicalTrials.gov ID: NCT04793958
Diagnosis Type: Colon Cancer
USOR Number: 20318

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)(VS-6766-201) (GOG 3052)

  • Details

ClinicalTrials.gov ID: NCT04625270
Diagnosis Type: Ovarian Cancer
USOR Number: 20298

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Myelomas

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase II trial of daratumumab, lenalidomide and dexamethasone (DRd) in combination with selinexor for patients with newly diagnosed multiple myeloma (USOR 20285)

  • Details

ClinicalTrials.gov ID: NCT04782687
Diagnosis Type: Myelomas
USOR Number: 20285

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Solid Tumors

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies after progression on prior PD-1 inhibitor treatment (SGN35-033)

  • Details

ClinicalTrials.gov ID: NCT04609566
Diagnosis Type: Solid Tumors
USOR Number: 20283

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Leukemia

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

An open label, multi-center Phase IIIb study of asciminib (ABL001) monotherapy in previously treated patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without T315I mutation (AIM4CML)(CABL001AUS04)

  • Details

ClinicalTrials.gov ID: NCT04666259
Diagnosis Type: Leukemia
USOR Number: 20282

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Lung Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 2 Trial of MRTX849 Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation (849-007)

  • Details

ClinicalTrials.gov ID: NCT04613596
Diagnosis Type: Lung Cancer
USOR Number: 20270

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants with Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)(67652000PCR3002)

  • Details

ClinicalTrials.gov ID: NCT04497844
Diagnosis Type: Prostate Cancer
USOR Number: 20248

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Carcinoid

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2) (INCMGA 0012-303)

  • Details

ClinicalTrials.gov ID: NCT04472429
Diagnosis Type: Carcinoid
USOR Number: 20189

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page

Carcinoid

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Corvallis

A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2) (INCMGA 0012-303)

  • Details

ClinicalTrials.gov ID: NCT04472429
Diagnosis Type: Carcinoid
USOR Number: 20189

  • Practice Details

444 NW Elks Drive
Corvallis, OR 97330
P: (541) 754-1256

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Willamette Valley Cancer Institute and Research Center - Eugene

An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (INCMGA 0012-204/ POD1UM-204)

  • Details

ClinicalTrials.gov ID: NCT04463771
Diagnosis Type: Endometrial Cancer
USOR Number: 20176

  • Practice Details

520 Country Club Rd
Eugene, OR 97401
P: (541) 683-5001

More Details View Practice Page